Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2023.1.19

D.I. Haurylenka, T.Y. Haurylenka, E.V. Rodina
Nutritional disorders in chronic liver diseases. Part 1. Diagnostic methods of nutritional disorders
Republican Research Centre for Radiation Medicine and Human Ecology, Gomel, Republic of Belarus

Vestnik VGMU. 2023;22(1):19-30.

Abstract.
Introduction. Malnutrition is a clinically significant condition and a predictor of poor outcomes in liver diseases. The first step towards minimizing poor outcomes is the alertness of clinicians regarding changes in nutritional status, the use of appropriate diagnostic methods that determine the volume and complex of preventive measures.
Objectives. To review in brief publications covering the problem of diagnosing malnutrition in chronic diffuse liver diseases.
Material and methods. The study and analysis of articles in English and Russian with a search depth of up to 30 years, contained in the PubMed, Cochrane Collaboration, UpToDate, eLIBRARY databases, were carried out. Key words and their combinations were: “body mass index”, “malnutrition”, “muscle wasting”, “nutrition risk”, “sarcopenia”, “nutrition status”, “complications of liver cirrhosis”.
Results. Recent data about changes in nutritional status, problems of diagnosing malnutrition and detecting nutritional risk in liver diseases have been considered. The most common and effective methods for assessing malnutrition are described both at the stage of primary diagnosis and during the dynamic monitoring of patients with chronic liver diseases.
Conclusions. Malnutrition and sarcopenia are associated with a poor prognosis with regard to severe, often fatal complications – hepatic encephalopathy, bacterial infections. The clinician must dynamically observe changes in nutritional status and apply available tools to identify the risk of malnutrition in patients with chronic liver diseases, based on the latest practical guidelines.
Keywords: liver cirrhosis, malnutrition, sarcopenia, nutritional status.

References

1. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019 Jan;70(1):172-93. doi: 10.1016/j.jhep.2018.06.024
2. Agarwal A, Avarebeel S, Choudhary NS, Goudar M, Tejaswini CJ. Correlation of Trace Elements in Patients of Chronic Liver Disease with Respect to Child- Turcotte- Pugh Scoring System. J Clin Diagn Res. 2017 Sep;11(9):OC25-OC28. doi: http://dx.doi.org/10.7860/JCDR/2017/26519.10655
3. Loguercio C, De Girolamo V, Federico A, Feng SL, Crafa E, Cataldi V, et al. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res. 2001 Sep;81(3):245-54. doi: http://dx.doi.org/10.1385/BTER:81:3:245
4. Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, et al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama. 2001 Dec;55(6):349-55. doi: http://dx.doi.org/10.18926/AMO/32003
5. Solis-Herruzo J, De Cuenca B, Munoz-Rivero MC. Intestinal zinc absorption in cirrhotic patients. Z Gastroenterol. 1989 Jun;27(6):335-8.
6. Pasqualetti P, Casale R, Colantonio D, Di Lauro G, Festuccia V, Natali L, et al. Serum levels of magnesium in hepatic cirrhosis. Quad Sclavo Diagn. 1987 Mar;23(1):12-7.
7. Nangliya V, Sharma A, Yadav D, Sunder S, Nijhawan S, Mishra S. Study of trace elements in liver cirrhosis patients and their role in prognosis of disease. Biol Trace Elem Res. 2015 May;165(1):35-40. doi: http://dx.doi.org/10.1007/s12011-015-0237-3
8. Büyükaşik NS, Nadır I, Akin FE, Cakal B, Kav T, Ersoy O, et al. Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description. Turk J Gastroenterol. 2011 Dec;22(6):606-11.
9. Jurczyk K, Wawrzynowicz-Syczewska M, Boroń-Kaczmarska A, Sych Z. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis. Med Sci Monit. 2001 Sep-Oct;7(5):962-5.
10. Rahelić D, Kujundzić M, Romić Z, Brkić K, Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol. 2006 Sep;30(3):523-8.
11. Teriaky A, Mosli M, Chandok N, Al-Judaibi B, Marotta P, Qumosani K. Prevalence of fat-soluble vitamin (A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation. Acta Gastroenterol Belg. 2017 Apr-Jun;80(2):237-41.
12. Chen W, Chen G. The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism. J Clin Med. 2014 May;3(2):453-79. doi: http://dx.doi.org/10.3390/jcm3020453
13. Saeed A, Hoekstra M, Hoeke MO, Heegsma J, Faber KN. The interrelationship between bile acid and vitamin A homeostasis. Biochim Biophys Acta Mol Cell Biol Lipids. 2017 May;1862(5):496-512. doi: http://dx.doi.org/http://dx.doi.org/10.1016/j.bbalip.2017.01.007
14. Kaplan MM, Elta GH, Furie B, Sadowski JA, Russell RM. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology. 1988 Sep;95(3):787-92. doi: http://dx.doi.org/10.1016/s0016-5085(88)80029-5
15. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening. Clin Nutr. 2003 Aug;22(4):415-21. doi: http://dx.doi.org/10.1016/s0261-5614(03)00098-0
16. Tandon P, Raman M, Mourtzakis M, Merli M. A practical approach to nutritional screening and assessment in cirrhosis. Hepatology. 2017 Mar;65(3):1044-57. doi: http://dx.doi.org/10.1002/hep.29003
17. Schlüssel MM, dos Anjos LA, Leite de Vasconcellos MT, Kac G. Reference values of handgrip dynamometry of healthy adults: a population-based study. Clin Nutr. 2008 Aug;27(4):601-7.  doi: http://dx.doi.org/10.1016/j.clnu.2008.04.004
18. Bankhead R, Boullata J, Brantley S, Corkins M, Guenter P, Krenitsky J, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009 Mar-Apr;33(2):122-67. doi: http://dx.doi.org/10.1177/0148607108330314
19. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: http://dx.doi.org/10.1093/ageing/afq034
20. Soeters PB, Reijven PLM, van Bokhorst-de van der Schueren MAE, Schols JMGA, Halfens RJG, Meijers JMM, et al. A rational approach to nutritional assessment. Clin Nutr. 2008 Oct;27(5):706-16. doi: http://dx.doi.org/10.1016/j.clnu.2008.07.009
21. Tandon P, Low G, Mourtzakis M, Zenith L, Myers RP, Abraldes JG, et al. A model to identify sarcopenia in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1473-80. doi: http://dx.doi.org/10.1016/j.cgh.2016.04.040
22. Eslamparast T, Montano-Loza AJ, Raman M, Tandon P. Sarcopenic obesity in cirrhosis – the confluence of 2 prognostic titans. Liver Int. 2018 Oct;38(10):1706-17. doi: http://dx.doi.org/10.1111/liv.13876
23. Bering T, Diniz KGD, Coelho MPP, Vieira DA, Soares MMS, Kakehasi AM, et al. Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C. J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):255-68. doi: http://dx.doi.org/10.1002/jcsm.12269
24. Carey EJ, Lai JC, Wang CW, Dasarathy S, Lobach I, Montano-Loza AJ, et al. Exercise in Liver Transplantation. A multicenter study to define sarcopenia in patients with end-stage liver disease. Liver Transpl. 2017 May;23(5):625-33. doi: http://dx.doi.org/10.1002/lt.24750
25. Chang K-V, Chen J-D, Wu W-T, Huang K-C, Lin H-Y, Han D-S. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis. J Formos Med Assoc. 2019 Apr;118(4):833-42. doi: http://dx.doi.org/10.1016/j.jfma.2018.09.011
26. Chinnaratha MA, Chaudhary S, Doogue M, McCormick RJ, Woodman RJ, Wigg AJ. Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Intern Med J. 2015 Dec;45(12):1230-5. doi: http://dx.doi.org/10.1111/imj.12866
27. Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition. 2015 Jan;31(1):193-9. doi: http://dx.doi.org/10.1016/j.nut.2014.07.005
28. Hara N, Iwasa M, Sugimoto R, Mifuji-Moroka R, Yoshikawa K, Terasaka E, et al. Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis. Intern Med. 2016;55(8):863-70. doi: http://dx.doi.org/10.2169/internalmedicine.55.5676
29. Kalafateli M, Mantzoukis K, Yau YC, Mohammad AO, Arora S, Rodrigues S, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score. J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):113-21. doi: http://dx.doi.org/10.1002/jcsm.12095
30. Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017 Aug;66(2):564-74. doi: http://dx.doi.org/10.1002/hep.29219
31. Lai JC, Dodge JL, McCulloch CE, Covinsky KE, Singer JP. Frailty and the Burden of Concurrent and Incident Disability in Patients with Cirrhosis: A Prospective Cohort Study. Hepatol Commun. 2019 Oct;4(1):126-33. doi: http://dx.doi.org/10.1002/hep4.1444
32. Lai JC, Rahimi RS, Verna EC, Kappus MR, Dunn MA, McAdams-DeMarco M, et al. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019 May;156(6):1675-82. doi: http://dx.doi.org/10.1053/j.gastro.2019.01.028
33. Klyaritskaya IL, Moshko YuA, Shelikhova EO, Semenikhina EV, Maksimova EV, Stilidi EI. The problem of malnutrition and sarcopenia in cirrhotic patients. Krym Terapevt Zhurn. 2019;(1):5-15. (In Russ.)
34. Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. MNA-International Group. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009 Nov;13(9):782-8. doi: http://dx.doi.org/10.1007/s12603-009-0214-7
35. Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, et al. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr. 1987 Jan-Feb;11(1):8-13. doi: http://dx.doi.org/10.1177/014860718701100108
36. Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019 Apr;38(2):485-521. doi: http://dx.doi.org/10.1016/j.clnu.2018.12.022
37. Koroleva M, Ilnitskiy A. Cellular chronoblockers and nutritional support for geriatric patients in the prevention of age-associated diseases and syndromes. Vrach. 2019;30(7):3-12. (In Russ.)
38. Wu Y, Zhu Y, Feng Y, Wang R, Yao N, Zhang M, et al. Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002. Br J Nutr. 2020 Dec;124(12):1293-302. doi: http://dx.doi.org/10.1017/S0007114520002366
39. Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr. 2020 Dec;39(12):3533-62. doi: http://dx.doi.org/10.1016/j.clnu.2020.09.001
40. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017 Jun;36(3):623-50. doi: http://dx.doi.org/10.1016/j.clnu.2017.02.013
41. Borhofen SM, Gerner C, Lehmann J, Fimmers R, Görtzen J, Hey B, et al. The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis. Dig Dis Sci. 2016 Jun;61(6):1735-43. doi: http://dx.doi.org/10.1007/s10620-015-4015-z

Information about authors:
D.I. Haurylenka – Candidate of Medical Sciences, functional diagnosis doctor, head of the department of functional diagnosis, Republican Research Center for Radiation Medicine and Human Ecology, https://orcid.org/0000-0001-7496-6164,
e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Dzmitry I. Haurylenka;
T.Y. Haurylenka – gastroenterologist, head of the reception department, Republican Research Centre for Radiation Medicine and Human Ecology;
E.V. Rodina – functional diagnosis doctor, Republican Research Centre for Radiation Medicine and Human Ecology.

Поиск по сайту